GlassScriptPhysician profile
Roberto Leon-Perez
NPI 1932197639
$17,101.84
in general payments reported to CMS, 2019-2025
20 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $1,640 · 2021: $6,745 · 2022: $4,558 · 2023: $1,197 · 2024: $737 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383 · Consulting Fee: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,383.34 |
| Consulting Fee | $825.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12,661.47 | 2019-2025 | |
| Amgen INC. | $1,413.82 | 2019-2025 | Evenity, Tavneos, Prolia |
| Novartis Pharmaceuticals Corporation | $644.81 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $508.84 | 2021-2023 | Xarelto, Tremfya |
| E.R. Squibb & Sons, L.L.C. | $429.24 | 2019-2025 | Orencia |
| Mallinckrodt Hospital Products INC. | $310.95 | 2020-2023 | Acthar |
| Glaxosmithkline, LLC. | $258.14 | 2021-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $162.25 | 2024 | Saphnelo |
| Radius Health, INC. | $155.81 | 2020-2025 | Tymlos |
| Boston Scientific Corporation | $110.38 | 2023 | Watchman Access System |
| Pfizer Pharmaceuticals LLC | $108.88 | 2019 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $99.53 | 2019 | |
| Merck Sharp & Dohme LLC | $63.22 | 2022 | |
| Lilly USA, LLC | $47.39 | 2019 | |
| Organon LLC | $39.46 | 2024-2025 | Hadlima, Renflexis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $31.72 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.46 | 2023 | Ofev |
| Ani Pharmaceuticals, INC. | $16.34 | 2024 | Purified Cortrophin Gel |
| Pbg Puerto Rico LLC | $11.14 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Leon-Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.